Predictmedix Inc. (PMED.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.91 Million CAD | 1.78% |
| 2022 | -1.94 Million CAD | -12.46% |
| 2021 | -1.73 Million CAD | 10.32% |
| 2020 | -1.93 Million CAD | -136.43% |
| 2019 | -816.65 Thousand CAD | -160.35% |
| 2018 | -313.68 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -258.25 Thousand CAD | 5.69% |
| 2024 Q1 | -273.84 Thousand CAD | 26.57% |
| 2023 Q4 | -372.92 Thousand CAD | 17.02% |
| 2023 FY | -1.98 Million CAD | -1.9% |
| 2023 Q1 | -472.32 Thousand CAD | 48.06% |
| 2023 Q3 | -449.41 Thousand CAD | 34.85% |
| 2023 Q2 | -689.79 Thousand CAD | -46.04% |
| 2022 Q2 | -373 Thousand CAD | -19.83% |
| 2022 FY | -1.94 Million CAD | -12.46% |
| 2022 Q4 | -909.32 Thousand CAD | -98.01% |
| 2022 Q3 | -459.22 Thousand CAD | -23.11% |
| 2022 Q1 | -311.26 Thousand CAD | 45.13% |
| 2021 FY | -1.73 Million CAD | 10.32% |
| 2021 Q2 | -358.36 Thousand CAD | 13.48% |
| 2021 Q1 | -414.18 Thousand CAD | 34.51% |
| 2021 Q3 | -396.04 Thousand CAD | -10.52% |
| 2021 Q4 | -567.29 Thousand CAD | -43.24% |
| 2020 FY | -1.93 Million CAD | -136.43% |
| 2020 Q1 | -331.24 Thousand CAD | -5.61% |
| 2020 Q3 | -493.84 Thousand CAD | -4.35% |
| 2020 Q2 | -473.26 Thousand CAD | -42.87% |
| 2020 Q4 | -632.47 Thousand CAD | -28.07% |
| 2019 Q4 | -313.65 Thousand CAD | -56.73% |
| 2019 Q3 | -200.12 Thousand CAD | -21.14% |
| 2019 Q1 | -124.04 Thousand CAD | -54.03% |
| 2019 FY | -816.65 Thousand CAD | -160.35% |
| 2019 Q2 | -165.19 Thousand CAD | -33.18% |
| 2018 Q3 | -116.5 Thousand CAD | -182.92% |
| 2018 FY | -313.68 Thousand CAD | 0.0% |
| 2018 Q4 | -80.53 Thousand CAD | 30.88% |
| 2018 Q2 | -41.18 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aquarius Surgical Technologies Inc. | -458.73 Thousand CAD | -316.955% |
| Cannabix Technologies Inc. | -2.96 Million CAD | 35.417% |